Ashland to pay $3.2bn for ISP
Ashland will buy International Specialty Products (ISP) in a deal designed to expand it's business in less cyclical, high-growth markets such as pharmaceuticals and personal care.
Archives for May 31, 2011
Pfizer seeks CROs for UK site as council waits for gov action
Pfizer continues to search for CROs to occupy a UK site but the local council is disappointed by the lack of governmental action.
Jubilant renames HollisterStier Contract Manufacturing
Indian CRAMS firm Jubilant Life Sciences has renamed HollisterStier Contract Manufacturing and hired a new BD exec in latest stage of North American reorganisation.
LabCorp to buy Clearstone to build Asia Pacific presence
LabCorp will buy Clearstone Central Labs in a deal that cements the firms’ existing clinical trial-focused collaboration.
update
GSK signs strategic deal with MaRS innovation
UK drug major GSK has entered into a ‘strategic partnership’ with MaRS Innovation, a Canadian group focused on harnessing the commercial potential of the discovery pipelines of 16 top Toronto academic institutions in its network.
Bilfinger Berger wins €30m deal for work on Genzyme plant
Bilfinger Berger has won a €30m ($43m) contract to help Genzyme add 8,000L of production capacity at its site in Geel, Belgium.